EnClear Therapies Announces Seed Funding and Senior R&D Appointment

49

CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear Therapies announced securing approximately $2 million in seed funding and hiring Kevin Kalish as Vice President of Research and Development. http://www.businesswire.com/news/home/20190314005058/en/EnClear-Therapies-Announces-Seed-Funding-Senior-Appointment/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==